Found: 2
Select item for more details and to access through your institution.
Phase I trial of copanlisib, a selective PI3K inhibitor, in combination with cetuximab in patients with recurrent and/or metastatic head and neck squamous cell carcinoma.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 6, p. 1641, doi. 10.1007/s10637-021-01152-z
- By:
- Publication type:
- Article
Correlation between changes in nutritional status and tumor response in patients receiving immunotherapy for lung cancer (NUTIMMUNO study)
- Published in:
- Supportive Care in Cancer, 2024, v. 32, n. 5, p. 1, doi. 10.1007/s00520-024-08519-x
- By:
- Publication type:
- Article